World Orphan Drug Congress USA 2012
Conference - Washington, D.C.
Strategy, regulation and opportunity for pharma, biotech and investors in rare diseases
This forum brings together leading pharma and biotech executives to strategize about the opportunities and challenges in commercializing treatments for rare and ultra-rare diseases.
The congress speaker faculty are business and scientific industry leaders from North America and beyond. An ability to meet decision-makers from big pharma, early stage and mid stage biotechs, government and regulatory bodies.
(Photo courtesy of www.terrapinn.com/.../networking.stm)
Tuesday, April 10 to Friday, April 13, 2012
Gaylord National Resort and Convention Center - Washington, D.C.
Contact: Michael Weinberg (michael.weinberg@terrapinn.com)
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.